Nissar A Darmani Selected Research

Nissar A Darmani Research Topics

Disease

45	Vomiting 04/2024 - 01/2002
12	Nausea 01/2023 - 01/2005
7	Neoplasms (Cancer) 06/2021 - 01/2005
2	Hyperphagia (Overeating) 01/2023 - 01/2006
2	Virus Diseases (Viral Diseases) 01/2023 - 06/2010
2	Pain (Aches) 09/2007 - 06/2005
1	Tourette Syndrome (Tourette's Syndrome) 11/2023
1	Motion Sickness (Airsickness) 01/2023
1	Gallbladder Diseases (Gall Bladder Disease) 01/2023
1	Bulimia (Binge Eating) 01/2023
1	Restless Legs Syndrome (Restless Legs) 11/2020
1	Parkinson Disease (Parkinson's Disease) 11/2020
1	Schizophrenia (Dementia Praecox) 11/2020

Drug/Important Bio-Agent (IBA)

26	AntiemeticsIBA 04/2024 - 01/2002
24	EmeticsIBA 04/2024 - 01/2002
20	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 01/2003
17	Serotonin (5 Hydroxytryptamine)IBA 04/2024 - 03/2004
15	Substance PIBA 04/2024 - 09/2005
12	CannabinoidsIBA 01/2020 - 01/2002
10	Palonosetron (Aloxi)FDA Link 06/2021 - 01/2014
9	RimonabantIBA 04/2024 - 01/2002
9	Dopamine (Intropin)FDA LinkGeneric 06/2021 - 01/2005
8	netupitantIBA 06/2021 - 04/2015
8	Neurotransmitter Agents (Neurotransmitter)IBA 05/2021 - 09/2005
7	Nifedipine (Adalat)FDA LinkGeneric 06/2021 - 01/2014
6	GR 73632IBA 04/2024 - 06/2008
6	5-HT3 Serotonin Receptors (5 HT3 Receptor)IBA 06/2021 - 01/2014
5	Dronabinol (THC)FDA LinkGeneric 01/2020 - 01/2002
5	TachykininsIBA 04/2015 - 06/2008
4	QuinpiroleIBA 04/2024 - 01/2005
4	FPL 64176IBA 04/2024 - 01/2014
4	Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA 01/2021 - 01/2013
4	Dantrolene (Dantrium)FDA LinkGeneric 01/2021 - 01/2014
4	Dopamine Agonists (Dopamine Agonist)IBA 11/2020 - 01/2005
4	EndocannabinoidsIBA 01/2014 - 09/2005
3	ThapsigarginIBA 04/2024 - 04/2016
3	U 0126 (UO 126)IBA 06/2021 - 01/2021
3	bisindolylmaleimide IIBA 01/2021 - 09/2018
3	3- (2- hydroxy- 4- (1,1- dimethylheptyl)phenyl)- 4- (3- hydroxypropyl)cyclohexanolIBA 12/2019 - 01/2003
3	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 12/2019 - 01/2005
3	Tropisetron (Navoban)IBA 08/2017 - 01/2009
3	CalciumIBA 01/2017 - 01/2014
3	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 04/2016 - 01/2014
3	Amlodipine (Norvasc)FDA LinkGeneric 05/2015 - 01/2014
3	Apomorphine FDA Link 05/2014 - 01/2005
3	Arachidonic Acid (Vitamin F)IBA 09/2010 - 01/2002
3	anandamide (arachidonylethanolamide)IBA 01/2006 - 06/2005
2	RolipramIBA 04/2024 - 01/2014
2	(4- (m- Chlorophenylcarbamoyloxy)- 2- butynyl)trimethylammonium ChlorideIBA 04/2024 - 05/2014
2	2-methyl-5-HTIBA 04/2024 - 01/2014
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2013
2	2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA 01/2021 - 09/2018
2	EnzymesIBA 11/2020 - 09/2005
2	Ion Channels (Ion Channel)IBA 11/2020 - 01/2014
2	resiniferatoxinIBA 01/2020 - 01/2014
2	CB2 Cannabinoid ReceptorIBA 12/2019 - 06/2007
2	5-Hydroxytryptophan (5 Hydroxytryptophan)IBA 12/2019 - 03/2004
2	2- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- oneIBA 09/2018 - 01/2014
2	pranlukastIBA 08/2017 - 02/2010
2	leukotriene D4 receptor (cysteinyl leukotriene receptor)IBA 08/2017 - 02/2010
2	LeukotrienesIBA 08/2017 - 02/2010
2	L-Type Calcium Channels (Dihydropyridine Receptor)IBA 05/2015 - 01/2014
2	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 04/2015 - 01/2014
2	Messenger RNA (mRNA)IBA 01/2013 - 01/2010
2	ProstaglandinsIBA 09/2010 - 09/2005
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2009 - 09/2005
2	Cannabinoid Receptors (Cannabinoid Receptor)IBA 06/2007 - 01/2005
2	Mesylates (Mesylate)IBA 06/2007 - 01/2003
2	glyceryl 2-arachidonate (2-arachidonoylglycerol)IBA 09/2005 - 01/2003
1	Dexmedetomidine FDA Link 04/2024
1	Clonidine (ST 155)FDA LinkGeneric 04/2024
1	ICI D2788IBA 04/2024
1	Yohimbine (Yocon)IBA 04/2024
1	5-HT2A Serotonin Receptor (5 HT2A Receptor)IBA 11/2023
1	Hallucinogens (Psychedelics)IBA 11/2023
1	Opiate AlkaloidsIBA 01/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	temsirolimus FDA Link 01/2022
1	MK 2206IBA 06/2021
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 06/2021
1	Glycogen Synthase Kinase 3IBA 06/2021
1	N- (4- methoxybenzyl)- N'- (5- nitro- 1,3- thiazol- 2- yl)ureaIBA 06/2021
1	perifosineIBA 06/2021
1	SB 216763IBA 06/2021
1	mu Opioid Receptors (mu Opioid Receptor)IBA 01/2021
1	Histamine (Histamine Dihydrochloride)FDA Link 01/2021
1	Protein Kinase CIBA 01/2021
1	1- (6- ((3- methoxyestra- 1,3,5(10)- trien- 17- yl)amino)hexyl)- 1H- pyrrole- 2,5- dioneIBA 01/2021
1	2,4,6- trimethyl- N- (meta- 3- trifluoromethylphenyl)benzenesulfonamideIBA 01/2021
1	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 01/2021
1	Type C PhospholipasesIBA 01/2021
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 01/2021
1	Sulpiride (neogama)IBA 01/2021
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 11/2020
1	LigandsIBA 11/2020
1	Dopamine Receptors (Dopamine Receptor)IBA 11/2020

Therapy/Procedure

9	Drug Therapy (Chemotherapy) 09/2018 - 07/2007
3	Therapeutics 01/2021 - 01/2017
2	Injections 02/2010 - 06/2009
2	Osteopathic Manipulation 09/2007 - 06/2005